SARS-CoV-2 coronavirus particles imaged using an electron microscope. (NIAID/National Institutes of Health/Science Photo Library)
WHO suspends hydroxychloroquine trial
The World Health Organization (WHO) has paused testing of hydroxychloroquine as a treatment for COVID-19 until safety risks can be analysed. A study of nearly 100,000 people linked the antimalarial drug to an elevated risk of death and abnormal heart rhythms when used as a coronavirus therapy. The drug is considered generally safe for treatment of autoimmune diseases and malaria. The other arms of the WHO’s global coronavirus mega-trial, SOLIDARITY, will continue to test three other treatments: remdesivir and two combinations of ritonavir, lopinavir and interferon beta-1a.BBC | 3 min read
Reference: The Lancet paper
.png)
No hay comentarios:
Publicar un comentario